Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARCHF4 antisense RNA 1 (MARCHF4-AS1) is a long non-coding RNA gene mapped to chromosome 2, transcribed in the antisense orientation relative to the MARCHF4 gene. As an antisense lncRNA, it does not code for protein; rather, similar transcripts frequently regulate their neighboring protein-coding genes (such as MARCHF4) through various mechanisms at the transcriptional or post-transcriptional level. There is no current published evidence describing a biological function, disease association, or direct interactors for MARCHF4-AS1 itself. No data support its usage as a therapeutic target, biomarker, or drug-binding molecule as of the information available in current biological databases and gene resources.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARCHF4 antisense RNA 1 (MARCHF4-AS1).